Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rougan Huoxue Formula (柔肝活血方) is a Traditional Chinese Medicine (TCM) herbal preparation primarily used for conditions involving liver dysfunction, such as chronic hepatitis B, hepatic fibrosis, and non-alcoholic steatohepatitis (NASH). Its therapeutic principles revolve around "softening/soothing the liver" (柔肝) and "activating blood circulation" (活血), aiming to nourish liver yin and blood, relieve pain, clear heat, and detoxify. Research indicates its potential to suppress the activation of hepatic stellate cells by downregulating the TGF-β1/Smads signaling pathway, and to attenuate NASH by enhancing fecal bile acid excretion. The formula typically comprises a combination of various herbs, each contributing to its overall therapeutic effect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rougan Huoxue Formula.